A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)
Clinical trial NCT05075824 · COMPLETED
Trial details
- NCT number
- NCT05075824
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-09
- Primary completion
- 2025-06-11
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.